Gabriella Macchia
Papers
2
Total Citations
67
H-Index
2
About
Gabriella Macchia is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) for challenging malignancies and the application of machine learning to personalize cancer treatment. Her major contributions are twofold: first, she has advanced the understanding of SBRT as a powerful tool for pain palliation in locally advanced pancreatic cancer, a disease with notoriously poor prognosis. Her seminal 2018 systematic review on this topic, which has garnered **64 citations**, remains a key reference for integrating SBRT into symptom management protocols. Second, Dr. Macchia is at the forefront of precision oncology, co-authoring the landmark ICAROS Study (2025), a multicenter investigation that developed a machine learning-based predictive model for acute toxicity in prostate cancer patients undergoing salvage radiotherapy. This work, already accumulating **3 citations** in its first year, promises to significantly refine patient selection and reduce treatment side effects. By bridging high-tech radiotherapy delivery with data-driven predictive analytics, Dr. Macchia is shaping a future where cancer care is both more effective and more tailored to the individual patient.
Research Focus
Key Achievements
Top Papers
- 1
- 2